ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

DATA Globaldata Plc

205.50
-1.50 (-0.72%)
Last Updated: 09:00:12
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Globaldata Plc LSE:DATA London Ordinary Share GB00BR3VDF43 ORD 1/100P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.50 -0.72% 205.50 204.00 207.00 207.00 205.50 207.00 113,910 09:00:12
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Miscellaneous Publishing 273.1M 30.8M 0.0364 56.46 1.74B

GlobalData PLC Update on FY21 performance and Capital Markets Day (8995X)

10/01/2022 7:00am

UK Regulatory


Globaldata (LSE:DATA)
Historical Stock Chart


From Apr 2021 to Apr 2024

Click Here for more Globaldata Charts.

TIDMDATA

RNS Number : 8995X

GlobalData PLC

10 January 2022

10 January 2022

GlobalData Plc

Update on FY21 performance and Capital Markets Day

Ahead of the full-year results, GlobalData Plc ("GlobalData" or the "Company", and together with its subsidiaries, the "Group"), the leading provider of industry intelligence, confirms that it expects to report another year of strong organic growth driven by its continued momentum in subscription revenue and further expansion of EBITDA margin.

For FY21, the Board expects like-for-like organic revenue growth(1) to be 8%, with currency volatility offsetting some gains to finish on revenue GBP189m, at an Adjusted EBITDA margin of 34% (2020: 32%) (which is within the consensus range(2) ). Invoiced Forward Revenue(3) is expected to finish with like-for-like organic growth of 9%.

GlobalData's strong organic growth is augmented with the strategic progress made through M&A in the last quarter of FY21, with the acquisitions of the Life Sciences business of IHS Markit, LMCA Holdings Limited and LMCI Holdings Limited. Whilst the timing of the acquisitions meant that the financial impact on FY21 was immaterial, the strengthening of the Group's capabilities in the Life Sciences, Automotive and Agribusiness sectors give it greater scale and opportunity for accelerated momentum in 2022.

The Group also announces that it will be hosting a Capital Markets Event for institutional investors and analysts on 27 January 2022. Should you wish to wish to attend, please register by emailing isingh@hudsonsandler.com . No new material financial or trading information will be disclosed during the event.

The Group will publish its full-year results on 28 February 2022.

Mike Danson, Chief Executive Officer, said:

"I am pleased to report that we expect our FY21 results to demonstrate further momentum and that we are on track to report another year of strong revenue growth and Adjusted EBITDA margin expansion.

Additionally, the two strategic acquisitions that we completed in the latter part of the year, mean that we enter 2022 with enhanced scale and additional capabilities. I would like to, again, take this opportunity to welcome all our new colleagues and I look forward to presenting our strategic update at the Capital Market Event on 27 January."

Notes

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon publication of this announcement, this inside information is now considered to be in the public domain.

(1) Like-for-like organic growth excludes the impact of currency movements and the benefit of acquisitions in the year.

(2) The company compiled consensus range for the year ended 31 December 2021 (FY21) is GBP188m to GBP190.3m for revenue and GBP63.5m to GBP64.5m for Adjusted EBITDA.

(3) Invoiced Forward Revenue relates to amounts that are invoiced to clients at the balance sheet date, which relate to future revenue to be recognised.

ENQUIRIES:

 
 GlobalData Plc 
 Mike Danson, Chief Executive Officer 
  Graham Lilley, Chief Financial Officer               0207 936 6400 
 Brokers 
 Bill Hutchings/ Mose Adigun - J.P. Morgan Cazenove 
  (Nomad and joint broker)                             0207 742 4000 
 Erik Anderson/ Alina Vaskina - Panmure Gordon 
  (Joint Broker)                                       020 7886 2500 
 Hudson Sandler 
 Nick Lyon                                             0207 796 4133 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TSTFIFVELDIILIF

(END) Dow Jones Newswires

January 10, 2022 02:00 ET (07:00 GMT)

1 Year Globaldata Chart

1 Year Globaldata Chart

1 Month Globaldata Chart

1 Month Globaldata Chart

Your Recent History

Delayed Upgrade Clock